National Health Investors Inc.
Last updated September 27, 2026
Organization details
- Legal name
- National Health Investors Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 6798 — Real Estate Investment Trusts
- Jurisdiction of incorporation
- Maryland
- Headquarters city
- Murfreesboro
- Headquarters state / province
- Tennessee
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NHI
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000877860
- EIN
- 62-1470956
Board of directors
-
Candice W. Todd · DirectorSince 2025
-
Charlotte A. Swafford · DirectorSince 2023
-
D. Eric Mendelsohn · Director · CEO and PresidentSince 2023
-
James R. Jobe · DirectorSince 2023
-
Lilly Donohue · DirectorSince 2026
-
Robert A. Mccabe Jr. · DirectorSince 2023
-
Robert Chapin · DirectorSince 2025
-
Robert G. Adams · DirectorSince 2023
-
Robert T. Webb · DirectorSince 2023
-
Tracy M. J. Colden · DirectorSince 2023
-
W. Andrew Adams · DirectorSince 2023
Chief executives
D. Eric Mendelsohn
· CEO and President
Dates unknown
Director election results
Annual meeting of May 21, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
48.1%
-
53.9%
-
94.1%
-
94.1%
Board connections
5 of this board's directors also sit on 4 other boards.
- via Robert G. Adams and W. Andrew Adams
- via Candice W. Todd
- via Robert A. Mccabe Jr.
- via Lilly Donohue
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $167,029
- 2 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 2026 | Maingot Christian Ken Officer (Chief Operating Officer) | Grant or award | +2,370 | — | — |
| Jun 15, 2026 | Robert A. Mccabe Jr. Director | Open-market purchase | +890 | $71.65 | $63,769 |
| Jun 5, 2026 | James R. Jobe Director | Gift | −225 | — | — |
| Jun 5, 2026 | D. Eric Mendelsohn Director, Officer (CEO and President) | Open-market purchase | +1,500 | $68.84 | $103,260 |
| May 5, 2026 | Spaid John L Officer (CFO/EVP Finance) | Shares withheld for tax | −314 | $73.09 | $22,950 |
| May 5, 2026 | D. Eric Mendelsohn Director, Officer (CEO and President) | Shares withheld for tax | −394 | $73.09 | $28,797 |
| May 5, 2026 | Travis David L Officer (SVP/Chief Accounting Officer) | Shares withheld for tax | −282 | $73.09 | $20,611 |
| Mar 3, 2026 | Lilly Donohue Director | Grant or award | +1,268 | — | — |
| Mar 3, 2026 | Tracy M. J. Colden Director | Grant or award | +1,268 | — | — |
| Mar 3, 2026 | Candice W. Todd Director | Grant or award | +1,268 | — | — |
| Mar 3, 2026 | Robert Chapin Director | Grant or award | +1,268 | — | — |
| Mar 3, 2026 | James R. Jobe Director | Grant or award | +1,268 | — | — |
| Mar 3, 2026 | Robert A. Mccabe Jr. Director | Grant or award | +1,268 | — | — |
| Mar 3, 2026 | Spaid John L Officer (CFO/EVP Finance) | Grant or award | +4,726 | — | — |
| Mar 3, 2026 | PASCOE KEVIN CARLTON Officer (Chief Investment Officer) | Grant or award | +5,072 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.